glp 1 with 3 receptors PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Emerging Frontiers in GLP-1 Therapeutics:

The general idea around microdosing GLP-1s is that you intentionally take a reduced amount of a medication

Heres what I tell my clients think about these four things: Are you in perimenopause, post-menopause, or another midlife transition

This shift represents a new era in diabetes care

Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J (2025) GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives

Also, the efficacy and safety of tirzepatide may have a wider perspective for its use beyond patients with T2DM or obesity [9, 10]